Zantac was first approved in 1983 and developed by GSK, becoming the world's fastest selling medication in 1988. In 2016, Sanofi acquired the treatment in an asset swap with Boehringer Ingelheim.

Just the second medication to garner more than $1 billion in annual sales, Zantac hit the US market as a prescription drug in 1983 before becoming an over-the-counter heartburn treatment in 1996.

The FDA banned sales of ranitidine in 2020 over possible contamination with the suspected carcinogen N-nitrosodimethylamine (NDMA. Some manufacturers of the drug voluntarily suspended sales in ...

In October, when GSK agreed to a $2.2 billion settlement to resolve approximately 80,000 lawsuits brought by users of Zantac, it appeared that the drugmaker’s legal issues with the heartburn ...

Discover all the brand names or Trade names of generic drug called Ranitidine ... and anyone looking to comprehend medication branding.